Press Releases
New Mass Detector for Flash Chromatography from Biotage
Biotage ,a leading global supplier of solutions and technology for analytical, medicinal and peptide chemistry, is pleased to announce the launch of Isolera™ Dalton 2000, a new mass detector for flash purification that expands functionality through a wider detection...
Press Releases
Glenmark and Americares India partner to create awareness about Hypertension among the Mumbai’smarginalize population
Glenmark Pharmaceuticals Limited in association with Americares India Foundation has initiated a week long awareness campaign on ‘Hypertension’ from May 15, 2017 to May 19, 2017 in Mumbai. May 17th is observed world-wide as the ‘World...
Press Releases
Aptar Pharma’s Electronic Lockout Device Approved by EMA
Aptar Pharma, a world leader in innovative drug delivery systems, is pleased to announce the approval by the EMA of the first integrated electronic nasal lockout device (e-Lockout) following a multi-year development with Takeda Pharmaceuticals International AG. ...
Press Releases
Clinerion presents tools to accelerate clinical research at São Paulo event
Clinerion launches a seminar event in São Paulo to introduce cutting-edge tools and technologies for the acceleration of clinical research. Clinerion will be running an open seminar event in São Paulo on May 15th, 2017,...
Press Releases
Clinical Studies: There Is So Much More Than Meets The Eye
If you have ever been involved in a clinical study or thought about it, you might want to take a little bit of time to learn more about the process. It might just surprise you how...
Press Releases
Videojet showcases four new products at Interpack 2017
Innovation is the focus in 2017, as Videojet showcases four brand new products from three technologies at Interpack designed to deliver maximum uptime, unprecedented reliability and attractive total cost of ownership figures. These four new systems...
Press Releases
Aldeyra Therapeutics Confirms FDA Orphan Drug Designation for ADX-102 in Sjogren-Larsson
Aldeyra Therapeutics, Inc. , a clinical-stage biotech company devoted to treating diseases thought to be related to endogenous aldehydes. A naturally occurring class of pro-inflammatory and toxic molecules announced that the United States FDA has granted Aldeyra's...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read